THB Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

THB Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,055,137	Closed	-$3.11M	–	262
2015 Q1	$3.11M	Buy	1,055,137 +232,673	+28%	+$762K	0.22%	167
2014 Q4	$3.65M	Buy	822,464 +595,380	+262%	+$2.84M	0.24%	143
2014 Q3	$1.17M	Buy	+227,084	New	+$1.21M	0.08%	213

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

THB Asset Management's ENZ Position: Q2 2015 in Review

THB Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2015, closing a stake of 1,055,137 shares — an estimated $3.11M sold.

THB Asset Management first reported a position in ENZ in Q3 2014 and held it in 3 quarters. The position peaked at $3.65M in Q4 2014. 86 funds tracked by Wall St. Rank hold ENZ as of Q2 2015.

THB Asset Management reported no remaining Enzo Biochem, Inc. position as of Q2 2015 after selling out during the quarter.
THB Asset Management sold 1,055,137 Enzo Biochem, Inc. shares in Q2 2015, an estimated $3.11M.
THB Asset Management first reported a position in Enzo Biochem, Inc. in Q3 2014 and held it in 3 quarters.
THB Asset Management's Enzo Biochem, Inc. position peaked at $3.65M in Q4 2014.
86 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2015.

Based on THB Asset Management's 13F filing for Q2 2015, filed 16 Jul 2015.